Table 5.

Results of peripheral blood immune cell test in OBI patients.

Group	Time	tLymph	CD3+ T	CD4+ T	CD8+ T	B
		$\left(\overline{\chi }\pm \text{SD}\right)$ /μl	$\left(\overline{\chi }\pm \text{SD}\right)$ /μl	$\left(\overline{\chi }\pm \text{SD}\right)$ /μl	$\left(\overline{\chi }\pm \text{SD}\right)$ /μl	$\left(\overline{\chi }\pm \text{SD}\right)$ /μl
Group A (n=44)	0 w	1801.00±445.30	1210.00±371.90	646.10±240.80	459.50±191.70	232.30±100.70
	12 w	1926.00±486.90a	1291.00±376.90	666.70±258.90	516.60±192.70ac	245.90±101.20
	24 w	1898.00±423.30a	1316.00±362.00a	661.20±240.40	494.90±188.80a	245.50±115.80
	36 w	1853.00±446.80a	1241.00±357.80	645.80±232.10	487.70±188.50ac	249.30±107.90ac
Group B (n=39)	0 w	1803.00±482.00	1211.00±373.00	634.60±231.60	445.40±201.20	222.50±106.40
	12 w	1802.00±481.20	1205.00±372.60b	631.20±228.90b	430.50±191.20	211.20±110.50
	24 w	1791.00±484.90	1208.00±340.90	630.60±203.30	417.00±191.40b	210.80±84.59
	36 w	1782.00±470.40	1187.00±340.30	619.20±231.10b	404.10±189.80b	206.80±82.79

^aThe difference was statistically significant compared with week 0 in Group A (P<0.05);

^bThe difference was statistically significant compared with week 0 in Group B (P<0.05);

^cThe difference was statistically significant compared with Group B (P<0.05).